CN Stock MarketDetailed Quotes

600200 JiangSu WuZhong Pharmaceutical Development

Watchlist
  • 8.48
  • +0.01+0.12%
Market Closed Jul 19 15:00 CST
6.04BMarket Cap-63759P/E (TTM)

JiangSu WuZhong Pharmaceutical Development Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

JiangSu WuZhong Pharmaceutical Development Earnings Date

Currency: CNY

Period

Q1 FY2024 Earnings

Apr 25, 2024

Revenue(YoY)

703.37M

+14.97%
EPS(YoY)

<0.01

-82.50%
Analyst Rating

Buy

Jul 20, 2024

JiangSu WuZhong Pharmaceutical Development Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 3.248B--
--2024/FY-- / 2.815B--
--2023/FY2.240B / 2.270B--
--2022/FY2.026B / 1.867B--
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 3.248B--
--2024/FY-- / 2.815B--
--2023/FY2.240B / 2.270B--
--2022/FY2.026B / 1.867B--
--------

Unlock Free Earnings Estimates

JiangSu WuZhong Pharmaceutical Development Earnings Reports

  • Jiangsu Wu Zhong Medicine Development Co., Ltd. 2023 Annual Report

    Apr 24 12:00 ET

  • Summary of the 2023 Annual Report of Jiangsu Wuzhong Pharmaceutical Development Co., Ltd.

    Apr 24 12:00 ET

  • Jiangsu Wu Zhong Medicine Development Co., Ltd. Report for the first quarter of 2024

    Apr 24 12:00 ET

  • Jiangsu Wuzhong Pharmaceutical Development Co., Ltd. 2023 Annual Results Pre-loss Announcement

    Jan 30 11:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 20, 2024

    Buy

    • Strong Buy

      40.00%

    • Buy

      60.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    %Chg